Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Polypill for Acute Coronary Syndrome
Sponsor: University of Texas Southwestern Medical Center
Summary
The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and uptake significantly contribute to risk or adverse events in the post-ACS period. This study is designed as a pragmatic, multi-center, randomized trial to assess the feasibility and effectiveness of a polypill-based strategy for treatment of ACS.
Official title: Polypill Strategy for the Treatment of Patients After Acute Coronary Syndromes - A Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2025-12-05
Completion Date
2030-07-31
Last Updated
2026-07-10
Healthy Volunteers
No
Conditions
Interventions
Polypill
The polypill is an inert capsule designed to combine multiple individual medications into a convenient, once-daily pill. In this case it will include DAPT and a statin.
Locations (2)
Baylor Scott and White Health System
Dallas, Texas, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States